These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 11107905)
1. [Neutralizing antibodies to 5 HIV-1 strains in macaques immunized with the multi-epitope polypeptide TAB9]. Navea Leyva LM; Lobaina Bartelemy L; Dubed Echevarría M; Alvarez Seguí G; Gómez Rodríguez C; Duarte Cano C Rev Cubana Med Trop; 2000; 52(2):115-8. PubMed ID: 11107905 [TBL] [Abstract][Full Text] [Related]
2. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine. Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388 [TBL] [Abstract][Full Text] [Related]
3. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope. Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547 [TBL] [Abstract][Full Text] [Related]
4. The multi-epitope polypeptide approach in HIV-1 vaccine development. Cano CA Genet Anal; 1999 Nov; 15(3-5):149-53. PubMed ID: 10596755 [TBL] [Abstract][Full Text] [Related]
5. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1. Bower JF; Green TD; Ross TM Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849 [TBL] [Abstract][Full Text] [Related]
6. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies. Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663 [TBL] [Abstract][Full Text] [Related]
7. Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins. Mascola JR; Sambor A; Beaudry K; Santra S; Welcher B; Louder MK; Vancott TC; Huang Y; Chakrabarti BK; Kong WP; Yang ZY; Xu L; Montefiori DC; Nabel GJ; Letvin NL J Virol; 2005 Jan; 79(2):771-9. PubMed ID: 15613305 [TBL] [Abstract][Full Text] [Related]
8. Heterologous neutralizing antibody induction in a simian-human immunodeficiency virus primate model: lack of original antigenic sin. Rasmussen RA; Montefiori DC; Robinson HL; McClure HM; Ruprecht RM J Infect Dis; 2001 Dec; 184(12):1603-7. PubMed ID: 11740737 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity. Braibant M; Brunet S; Costagliola D; Rouzioux C; Agut H; Katinger H; Autran B; Barin F AIDS; 2006 Oct; 20(15):1923-30. PubMed ID: 16988513 [TBL] [Abstract][Full Text] [Related]
10. A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers. Toledo H; Baly A; Castro O; Resik S; Laferté J; Rolo F; Navea L; Lobaina L; Cruz O; Míguez J; Serrano T; Sierra B; Pérez L; Ricardo ME; Dubed M; Lubián AL; Blanco M; Millán JC; Ortega A; Iglesias E; Pentón E; Martín Z; Pérez J; Díaz M; Duarte CA Vaccine; 2001 Jul; 19(30):4328-36. PubMed ID: 11457560 [TBL] [Abstract][Full Text] [Related]
11. Effect of epitope position on neutralization by anti-human immunodeficiency virus monoclonal antibody 2F5. Ou W; Lu N; Yu SS; Silver J J Virol; 2006 Mar; 80(5):2539-47. PubMed ID: 16474160 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies. Bower JF; Li Y; Wyatt R; Ross TM Vaccine; 2006 Jun; 24(26):5442-51. PubMed ID: 16621193 [TBL] [Abstract][Full Text] [Related]
13. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P). Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906 [TBL] [Abstract][Full Text] [Related]
14. Cynomolgus macaques immunized with two HIV-1 Tat stabilized proteins raise strong and long-lasting immune responses with a pattern of Th1/Th2 response differing from that in mice. Turbant S; Martinon F; Moine G; Le Grand R; Léonetti M Vaccine; 2009 Aug; 27(39):5349-56. PubMed ID: 19607953 [TBL] [Abstract][Full Text] [Related]
15. Development and studies of the anti-R7V neutralizing antibody ELISA test: a new serological test for HIV seropositive patients. Sanchez A; Gemrot F; Da Costa Castro JM J Immunol Methods; 2008 Mar; 332(1-2):53-60. PubMed ID: 18234206 [TBL] [Abstract][Full Text] [Related]
16. Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation. Buonaguro L; Visciano ML; Tornesello ML; Tagliamonte M; Biryahwaho B; Buonaguro FM J Virol; 2005 Jun; 79(11):7059-67. PubMed ID: 15890945 [TBL] [Abstract][Full Text] [Related]
17. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques. Egan MA; Chong SY; Hagen M; Megati S; Schadeck EB; Piacente P; Ma BJ; Montefiori DC; Haynes BF; Israel ZR; Eldridge JH; Staats HF Vaccine; 2004 Sep; 22(27-28):3774-88. PubMed ID: 15315859 [TBL] [Abstract][Full Text] [Related]